Drug compliance and identity: reasons for non-compliance: Experiences of medication from persons with asthma/allergy

https://doi.org/10.1016/S0738-3991(03)00199-XGet rights and content

Abstract

The aim of the study was to describe patient experiences of medication. Patients with asthma/allergy were interviewed in depth twice with 8 years between. The interviews were analysed according to the phenomenographic approach and three categories, one with four sub-categories, were identified: ‘access to medicine is important to relieve discomfort and to avoid fear’, ‘medicine damages your body and your identity without curing the illness’ (because ‘you can become immune or addicted’, ‘the ability of your body to heal itself is weakened’, ‘your body’s own signals are camouflaged’ and ‘you become stigmatised’) and ‘production and distribution of medicine is a profit-seeking commercial undertaking which is not primarily aimed at curing the patient’. Medication experiences were stable over time. Sociological and biological survival must be compared in an open discussion along with the patient’s and health professional’s different reasons for how they take or prescribe medication.

Introduction

Low rates of compliance have been seen as one of the most serious problems facing medical practice [1]. They pose a major challenge to effective management of most chronic diseases, including asthma [2]. About 50% of patients who suffer from chronic diseases are not compliant regarding the taking of medication [3]. Within the asthma field, estimates of compliance range between 20 and 80% of prescribed therapy [4], [5]. The great variety is largely due to methodological problems when measuring compliance [6].

Compliance is originally a military term [7]. Within the health and medical care sector it generally means following a recommended treatment regimen. It is grounded in the communication between doctor and patient where the patient is obedient, trustful and passive, while the doctor is paternal, authoritarian and active. The term compliance is criticised especially from social scientists [8], [9] and health care ethicists [10] as being judgmental: there is something wrong with non-compliant patients.

No absolute answers as to why patients do not comply have been found and there is little evidence of sustained success from the many efforts to improve compliance [11]. In a review, it is concluded that optimum benefits of medications cannot be obtained at currently achievable levels of compliance. Prevalent methods of improving compliance are not sufficient and there is a need for new methods [12]. A new relationship between patient and prescriber as equals, who have established a true partnership, a ‘therapeutic alliance’, has been advocated [3]. Such a relationship should be based on respect for the patient’s beliefs and wishes, without diminishing the doctor’s, and on openness, ‘so that both doctor and patient together can proceed on the basis of reality and not of misunderstanding, distrust or concealment’ ([3], p. 8). The aim is to attain a negotiated agreement, ‘concordance’. Though this relationship is mutual, the decisions made by the patient are regarded to be the most important. Marinker [13] points out that by respecting the patient’s autonomy when inviting to discussion, a negotiation about the appropriate intervention is possible, which may end up in a sub-optimal treatment. But he continues that a negotiated consensus is more likely to result in behaviour change than paternalistic direction. Also in the asthma field, partnership has been recommended [14]. Instead of a doctor-oriented communication, partnership requires patient orientation [15], [16], [17], i.e. not only the medical but particularly the patient’s experiences are to be attended to.

Patient experiences of medication have been the focus of several studies, showing that non-compliance is not a disobedient behaviour, but an adequate, rational act from the meaning the patient ascribes medication [18], [19], [20], [21], [22], [23], [24].

The beliefs that people hold about drugs are suggested to be of utmost importance for medicine taking, and as they often not are in line with the stance of medical science they consequently receive minimal attention from the prescriber [3].

The present study was grounded in the assumption that people have good reasons for being non-compliant, grounded in their own experiences of medicine and medication. The purpose of the study was to find out how those with asthma/allergy experience prescribed medicine and medication, and to investigate any changes to these experiences over time. Unlike most studies within this field, this study has a longitudinal design. The ultimate goal is to bring about learning by making the patient’s concrete sensory experiences and reasons for how to take medicine as important as the prescribing professional’s reasons for the prescription. Thereby, it might be possible to attain concordance and hopefully bring about an improvement in the individual patient’s life situation.

Section snippets

Phenomenography

Phenomenography [25] is an empirical, qualitative research approach. It was developed within the framework of educational research in response to educational questions at the Department of Education and Educational Research at the University of Göteborg, Sweden in the early 1970s, given its name by Marton and inspired by phenomenology although it does not share its philosophical assumptions [26]. A phenomenographic study by Säljö [27] was replicated by Giorgio [28], using a phenomenological

Results

The interview subjects’ experiences of prescribed medicine and medication were categorised in the following way. One of the categories comprises four sub-categories:

  • (A)

    Access to medicine is important to relieve discomfort and to avoid fear.

  • (B)

    Medicine damages your body and your identity without curing the illness.

    • (B1)

      You can become immune or addicted.

    • (B2)

      The ability of your body to heal itself is weakened.

    • (B3)

      Your body’s own signals are camouflaged.

    • (B4)

      You become stigmatised.

  • (C)

    Production and distribution of medicine

Discussion and conclusion

The patients in this study ascribed different meanings to medicine and medication experiences, and these meanings were stable over 8 years. Access to medicine was experienced as relieving discomfort and minimising fear, but medicine was also experienced as causing damage to body and identity without curing the illness. Production and distribution of medicine was seen as a profit-seeking commercial undertaking, which was not primarily aimed at curing the patient.

The phenomenographic approach was

References (43)

  • G.M. Cochrane

    Therapeutic compliance in asthma; its magnitude and implications

    Eur. Respir. J.

    (1992)
  • C.S. Rand et al.

    Measuring adherence to asthma medication regimens

    Am. J. Respir. Crit. Care Med.

    (1994)
  • J. Urquhart

    Role of patient compliance in clinical pharmacokinetics. A review of recent research

    Clin. Pharmacokinet.

    (1994)
  • S. Holm

    What is wrong with compliance?

    J. Med. Ethics

    (1993)
  • McGavock HA, Britten N, Weinman J. A review of the literature on drug adherence. London: Royal Pharmaceutical Society...
  • Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow...
  • M. Marinker

    The current status of compliance

    Eur. Respir. Rev.

    (1998)
  • US Department of Health and Human Services. International consensus report on diagnosis and treatment of asthma...
  • Byrne PS, Long BEL. Doctors talking to patients. The Royal College of General Practitioners, no. 110. Exeter;...
  • R.J. Henbest et al.

    A patient-centredness in the consultation. 2. Does it really make a difference?

    Fam. Pract.

    (1989)
  • McWhinney IR. A textbook on family medicine, second ed. Oxford: Oxford University Press;...
  • Cited by (56)

    • A systematic review and thematic synthesis of patients’ experience of medicines adherence

      2017, Research in Social and Administrative Pharmacy
      Citation Excerpt :

      Studies often reported a seemingly pre-predicative dislike for medicines engendered through fear of uncertainty,19,25,27,33,37,38,40,42,44 dependency,33,37,45 and illicit drug taking38 tempered only by hope.28,34 Uncertainty was often described as experiencing a lack of knowledge19,28,32,34,36,38–40,42,45 and related to patients accepting the biological causes of their illness30,33,35,37 or adoption of natural or alternative therapies.27,34,35,42,45 Participants reported receiving knowledge,31,39 obtaining knowledge,19,32 and being ‘convinced’ to use medicines.30,40

    • Patient-physician communication about work-related asthma: What we do and do not know

      2015, Annals of Allergy, Asthma and Immunology
      Citation Excerpt :

      In addition to adverse socioeconomic outcomes, WRA has been associated with disability and mortality.5,9–14 Establishing effective patient–physician communication offers multiple benefits to patients and physicians.15–20 Good communication increases patient involvement and treatment compliance, increases patient satisfaction, improves quality of care and health outcomes, and decreases the frequency of malpractice claims.

    • Physician-patient communication regarding asthma and work

      2012, American Journal of Preventive Medicine
      Citation Excerpt :

      Moreover, it can result in lost opportunities to implement primary, secondary, or tertiary prevention measures in the workplace.2,32,33 Establishing effective communication with patients can also facilitate understanding of medical information,10 increase patients' compliance with a recommended treatment,34 reduce diagnostic testing,35 and reduce malpractice risk.36,37 Communication about asthma and work was based on self-report.

    View all citing articles on Scopus
    View full text